WHO says one dose of H1N1 vaccine sufficient
This article was originally published in Scrip
The World Health Organization has recommended that only one dose of H1N1 vaccine – including approved live attenuated and adjuvanted and non-adjuvanted inactivated products – is needed to protect against the influenza pandemic in those aged 10 years or over. Teenagers and young adults continue to make up the bulk of H1N1 cases, with rates of hospitalisation highest in very young children.
You may also be interested in...
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.
It seems as if the US FDA is softening its stance on assessing the quality of pharmaceutical manufacturing facilities around the world in future, with an apparent desire to work more closely with other drug regulators. However, incorporating the regulators from countries such as India, China and Japan into a global inspectorate still looks problematical.
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.